by University of Barcelona (A) Illustration of Three Trials to Measure Contrast Sensitivity. (B) Contrast Sensitivity in Individuals with Schizophrenia and Healthy Controls for Schwartz and Winstead (1985). A Small Jitter in Spatial Frequency Between Groups is Added to Minimize Overlap. Error Bars are Standard Errors of the Mean. (C) Estimated Hedges’ g for the Same...
Tag: <span>Schizophrenia</span>
Brain-cell ‘periodic table’ for psychiatric disorders reveals new schizophrenia clues
by Bruce Goldman, Stanford University Approach for systematically testing 461 human brain cell types for association with schizophrenia (and other phenotypes tested). Credit: Nature Neuroscience (2025). DOI: 10.1038/s41593-024-01834-w Stanford Medicine scientists are generating a periodic table of sorts for psychiatric disorders, providing a better understanding of these conditions and paving the way toward targeted treatment. By combining two...
Study reveals immune system changes linked to schizophrenia and treatment resistance
by Agency for Science, Technology and Research (A*STAR), Singapore Credit: Unsplash/CC0 Public Domain Researchers from Singapore’s National Healthcare Group (NHG)’s Institute of Mental Health (IMH) and Agency for Science, Technology and Research (A*STAR) have made strides in understanding the connection between the immune system and resistance to antipsychotic medications in schizophrenia, using changes in immune cell...
COULD AN EYE TEST SPOT SCHIZOPHRENIA?
JANUARY 2ND, 2025POSTED BY YALE (Credit: Getty Images) SHARE THIS ARTICLE You are free to share this article under the Attribution 4.0 International license. TAGS UNIVERSITY YALE UNIVERSITY Could complex beliefs like paranoia have roots in something as basic as vision? A new study finds evidence that they might. When completing a visual perception task, in which participants...
Schizophrenia: Researchers observe disease processes in nerve cells
by Jörg Schäfer, NMI Naturwissenschaftliches und Medizinisches Institut in Reutlingen Example ICC images of marker expression in iPSC (left) and NPC (right) obtained by high-content microscopy. Credit: BMC Psychiatry (2024). DOI: 10.1186/s12888-024-06127-x Up to now, schizophrenia has mainly been treated symptomatically, as little is known about the exact underlying processes. Researchers at the NMI Natural and Medical...
Genetic risk for schizophrenia linked to a malformed skull
by St. Jude Children’s Research Hospital Research from the Zakharenko lab, St. Jude Department of Developmental Neurobiology published in Nature Communications revealed a gene deleted in 22q11.2 deletion syndrome results in malformed regions of the cerebellum, but the defect is a result of a local skull deformity. Pictured: first author on the paper Tae-Yeon Eom, PhD....
Intermittent theta burst stimulation found to more effective for treating schizophrenia symptoms than other approaches
by Fujita Health University In a study published in JAMA Network Open, researchers from Fujita Health University, Japan conducted a systematic review and network meta-analysis using published data and verify the efficacy and safety of TBS protocols for schizophrenia. Credit: Public Relations Department, Fujita Health University, Japan Schizophrenia, which is characterized by positive symptoms (e.g., hallucinations and...
Brain plasticity expert Peter Falkai discusses new pathways for treating schizophrenia
Max Planck Institute director Prof. Peter Falkai shares groundbreaking research insights in exclusive Genomic Press InterviewReports and Proceedings Genomic Press image: Peter Falkai, MD, PhD, Munich University Hospital, Germanyview more Credit: Peter Falkai, MD, PhD MUNICH, Germany, 19 November 2024 – In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new directions...
FDA approves Cobenfy for adults with schizophrenia
by Lori Solomon The U.S. Food and Drug Administration has approved Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults. The oral medication represents the first new class of medicine in several decades and selectively targets M1 and M4 receptors in the brain, without blocking D2 receptors. The approval is...
Psychedelic use linked to increased risk of schizophrenia, study finds
Peer-Reviewed Publication Institute for Clinical Evaluative Sciences image: Infographic: Myran et al. JAMA Psych. 2024view more Credit: ICES Ottawa, ON, November 13, 2024 – Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, according to a new study from researchers at ICES, The Ottawa Hospital, University of Ottawa’s Department of Family...